A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.
Also called NCT02452632
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 143 participants
- Sponsor
- Registry
-
NCT02452632
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02452632. Randomized; quadruple masking; primary purpose treatment. Start 2015-06-22 (actual); primary completion 2017-01-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ASP1941
- Intervention (Drug)
- Placebo
- Lead sponsor
- Astellas Pharma Korea, Inc.
Record details
- Record id
cardio:ct-nct02452632- Content hash
62e6bae88ab2a56c7303cadc31811e1501253e80a6a105d68094d56e1dbac80a